Skip to main content
Log in

Schizophrenie und Depression

Schizophrenia and depression

  • Originalien
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Der Vergleich der von Psychopharmaka noch unbeeinflussten Entwicklung von Symptomen und sozialer Rollenkompetenz schizophren und unipolar depressiv Erkrankter mit gesunden Kontrollen gibt Aufschluss über den Frühverlauf beider Krankheiten.

Stichproben und Methoden

Drei Stichproben wurden mit IRAOS und mehreren Querschnittsinstrumenten zur Symptomatik, funktionellen Beeinträchtigung und sozialen Behinderung untersucht und verglichen.

Ergebnisse

In frühen Stadien überlappen sich Symptom- und Beeinträchtigungsmuster von Schizophrenie und schwerer Depression. Erst im weiteren Verlauf entwickeln sich mit dem Auftreten psychotischer Symptome beide Krankheiten auseinander. Depressive Symptome erreichen ihr Maximum in der ersten und in nachfolgenden psychotischen Episoden und sinken mit der Remission wieder ab. Depressive Patienten berichten für die Zeit vom Erkrankungsbeginn bis zur Erstaufnahme über mehr funktionelle Beeinträchtigung und soziale Behinderung als schizophren Erkrankte, was auf Unterschiede kognitiver Bewertung zurückzuführen ist.

Schlussfolgerung

Aufgrund der Symptomentwicklung und der früh auftretenden sozialen Beeinträchtigung scheint eine Früherkennung von Schizophrenie oder Depression möglich zu sein. Eine frühe diagnostische Unterscheidung und Vorhersage von Psychose- vs. Depressionsrisiko ist in der präpsychotischen Prodromalphase wegen Überlappung von Symptomatik und Beeinträchtigungsmustern nicht aussichtsreich.

Summary

Background

Comparison of symptom-related and social role development between patients with schizophrenia, major depression and healthy controls provided insights into the untreated early course of the two disorders.

Samples and methods

Symptoms, functional impairment and social disability were assessed and compared using the IRAOS and several other cross-sectional instruments in three samples.

Results

At the early illness stages there was considerable overlap in the symptom patterns and impairments presented by persons with schizophrenia and severe depression.The two disorders did not diverge until later in the early illness course with the onset of psychotic symptoms. Depressive symptoms showed a maximum in the first psychotic episode and relapse episodes and decreased with the remitting episode. Due to differences in cognitive appraisal depressed patients reported more functional impairment and social disability than patients with schizophrenia did.

Conclusion

The early course of symptoms and social impairment in schizophrenia and depression seems to offer an opportunity to distinguish these disorders from variants of normal development fairly early. However, early diagnostic distinction and prediction of psychosis versus depression risk at the prepsychotic prodromal stage do not seem promising due to the broad overlap in symptoms and impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Notes

  1. Die relativ hohen Prävalenzraten depressiver Symptome in der gesunden Vergleichsgruppe haben damit zu tun, dass es sich um kumulative Werte durchschnittlich über mehr als 8 Jahre handelt. Nicht nur Diagnosen, sondern auch Einzelsymptome wie depressive Verstimmung sind erfasst worden. Die Raten sind deshalb mit den Diagnose- oder Krankheitsprävalenzraten aus Bevölkerungsstudien nicht vergleichbar.

Literatur

  1. Addington D, Addington J, Patten S (1998) Depression in people with first-episode schizophrenia. Br J Psychiatry 172:90–92

    CAS  PubMed  Google Scholar 

  2. an der Heiden W, Könnecke R, Maurer K et al. (2005) Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci Special Issue (in press)

  3. Andreasen NC (1983) The scale for the assessment of negative symptoms (SANS). University of Iowa, Iowa City

  4. Angst J (1986) The course of schizoaffective disorders. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 63–93

  5. Angst J (1995) Psychotic continuum or distinct entities: discussion. In: Marneros A, Andreasen NC, Tsuang MT (eds) Psychotic continuum. Springer, Berlin Heidelberg New York, pp 87–88

  6. Ayuso-Mateos JL, Vásquez-Barquero JL, Dowrick C et al. (2001) Depresssive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 179:308–316

    Article  CAS  PubMed  Google Scholar 

  7. Barkow K, Maier W, Üstün TB et al. (2002) Risk factors for new depressive episodes in primary health care: an international prospective 12-month follow-up study. Psychol Med 32:595–607

    Article  CAS  PubMed  Google Scholar 

  8. Bebbington P, Wilkins S, Jones PB et al. (1993) Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 162:72–79

    CAS  PubMed  Google Scholar 

  9. Beck AT (1978) Beck depression inventory. Harcourt Brace Jovanovich, New York

  10. Berrettini W (2003) Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet 123C:59–64

    Article  Google Scholar 

  11. Biehl H, Maurer K, Jablensky A et al. (1989) The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept. Br J Psychiatry 155(Suppl 7):68–70

  12. Birchwood M (2003) Pathways to emotional dysfunction in first-episode psychosis. Br J Psychiatry 182:373–375

    Article  PubMed  Google Scholar 

  13. Birchwood M, Mason R, Macmillan F et al. (1993) Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 23:387–395

    CAS  PubMed  Google Scholar 

  14. Bottlender R, Strauss A, Möller H-J (2000) Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophr Res 44:145–150

    Article  CAS  PubMed  Google Scholar 

  15. Bühler B, Hambrecht M, Löffler W et al. (2002) Precipitation and determination of the onset and course of schizophrenia by substance abuse—a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res 54:2243–2251

    Google Scholar 

  16. Carpenter WT, Buchanan RW, Kirkpatrick B (1995) Schizophrenia: disease entity, disease entities, or domains of psychopathology. In: Marneros A, Andreasen NC, Tsuang MT (eds) Psychotic continuum. Springer, Berlin Heidelberg New York, pp 137–149

  17. Crow TJ (1986) The continuum of psychosis and its implications for the structure of the gene. Br J Psychiatry 149:419–429

    CAS  PubMed  Google Scholar 

  18. Crow TJ (1995) Psychotic continuum or disease entities? The critical impact of nosology on the problem of aetiology. In: Marneros A, Andreasen NC, Tsuang MT (eds) Psychotic continuum. Springer, Berlin Heidelberg New York, pp 151–163

  19. Dohrenwend BP, Shrout PE, Link BG et al. (1995) Life events and other possible psychosocial risk factors for episodes of schizophrenia and major depression: a case-control study. In: Mazure CM (ed) Does stress cause psychiatric illness? American Psychiatric Press, Washington D.C., pp 43–65

  20. Done D, Crow TJ, Johnstone EC et al. (1994) Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. Br Med J 309:699–703

    CAS  Google Scholar 

  21. Done DJ, Sacker A, Crow TJ (1994) Childhood antecedents of schizophrenia and affective illness: intellectual performance at ages 7 and 11. Schizophr Res 11:96–97

    Google Scholar 

  22. Elkis H, Friedman L, Wise A et al. (1995) Meta-analysis of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry 52:735–746

    CAS  PubMed  Google Scholar 

  23. Erlenmeyer-Kimling L, Rock D, Squires-Wheeler E et al. (1991) Early life precursors of psychiatric outcomes in adulthood of subjects at risk for schizophrenia or affective disorders. Psychiatry Res 39:239–256

    Article  CAS  PubMed  Google Scholar 

  24. Gattaz WF, Abrahao AL, Foccacia R (2004) Childhood meningitis and adult schizophrenia. In: Gattaz WF, Häfner H (eds) Search for the causes of schizophrenia, vol 5. Steinkopff, Darmstadt, pp 26–31

  25. Griesinger W (1861) Die Pathologie und Therapie der psychischen Krankheiten für Aerzte und Studirende, 2. Aufl. Adolph Krabbe, Stuttgart

  26. Häfner H (2004) Schizophrenia and depression. Paper presented at the 12th Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, 7–13 February 2004

  27. Häfner H (2005) Das Rätsel Schizophrenie — Eine Krankheit wird entschlüsselt. 3. vollst. überarb. Aufl. CH Beck, München

  28. Häfner H, Maurer K (2001) The prodromal phase of psychosis. In: Miller T, Mednick SA, McGlashan T et al. (eds) Early intervention in psychotic disorders. Kluwer, Dordrecht, pp 71–100

  29. Häfner H, Maurer K (2004) Prodromal symptoms and early detection of schizophrenia. In: Maj M (ed) Early detection and management of mental disorders. Wiley, London (in print)

  30. Häfner H, Riecher A, Maurer K et al. (1990) Ein Instrument zur retrospektiven Einschätzung des Erkrankungsbeginns bei Schizophrenie [Instrument for the retrospective assessment of the onset of schizophrenia—“IRAOS“]—Entwicklung und Ergebnisse. Z Klin Psychol 19:230–255

    Google Scholar 

  31. Häfner H, Maurer K, Löffler W et al. (1993) The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 162:80–86

    CAS  PubMed  Google Scholar 

  32. Häfner H, Nowotny B, Löffler W et al. (1995) When and how does schizophrenia lead to social deficits? Eur Arch Psychiatry Clin Neurosci 246:17–28

    PubMed  Google Scholar 

  33. Häfner H, Maurer K, Löffler W et al. (1998) The ABC schizophrenia study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 33:380–386

    Article  PubMed  Google Scholar 

  34. Häfner H, Löffler W, Maurer K et al. (1999) Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 100:105–118

    Google Scholar 

  35. Häfner H, Löffler W, Maurer K et al. (1999) IRAOS Interview für die retrospektive Erfassung des Erkrankungsbeginns und -verlaufs bei Schizophrenie und anderen Psychosen. Huber, Bern

  36. Häfner H, Maurer K, Löffler W et al. (1999) Onset and prodromal phase as determinants of the course. In: Gattaz WF, Häfner H (eds) Search for the causes of schizophrenia, vol. IV: balance of the century. Steinkopff, Darmstadt, and Springer, Berlin Heidelberg New York Tokyo, pp 35–58

  37. Häfner H, Maurer K, Löffler W et al. (2002) The early course of schizophrenia. In: Häfner (ed) Risk and protective factors in schizophrenia. Steinkopff, Darmstadt, pp 207–228

  38. Häfner H, Löffler W, Maurer K et al. (2003) IRAOS—Interview for the retrospective assessment of the onset and course of schizophrenia and other psychoses. Hogrefe & Huber, Göttingen

  39. Häfner H, Maurer K, Ruhrmann S et al. (2004) Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 254:117–128

    Article  PubMed  Google Scholar 

  40. Häfner H, Mauser K, Trendler G, an der Heiden N, Schmidt M, Konnecke R (2005) Schizophrenia and depression. Challenging the paradigm of two seperate diseases. Schizophr Res

  41. Hambrecht M, Häfner H (2002) Temporal order and aetiology. In: Graham HL, Copello A, Birchwood MJ et al. (eds) Substance misuse in psychosis. Wiley, Chichester, pp 24–42

  42. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    CAS  PubMed  Google Scholar 

  43. Hanssen M, Bijl RV, Vollebergh W et al. (2003) Self-reported psychotic experiences in the general population: a valid screening tool for DSM-III-R psychotic disorders? Acta Psychiatr Scand 107:369–377

    Article  CAS  PubMed  Google Scholar 

  44. Hanssen M, Bak M, Bijl R et al. (2004) Outcome of self-reported psychotic experiences in the general population: a prospective study. In: Hanssen M (ed) A continuous psychosis phenotype: from description to prediction. (South-Limburg Mental Health Research and Teaching Network PHD Series). Hanssen, Maastricht, pp 95–107

  45. Jackson H (1887) Remarks on evolution and dissolution of the nervous system. J Ment Sci 33:25–48

    Google Scholar 

  46. Janzarik W (1988) Strukturdynamische Grundlagen der Psychiatrie. Enke, Stuttgart

  47. Jones P, Done DJ (1997) From birth to onset: a developmental perspective of schizophrenia in two national birth cohorts. In: Keshavan MS, Murray RM (eds) Neurodevelopmental models of psychopathology. Cambridge University Press, Cambridge, pp 119–136

  48. Jones PB, Harvey I, Lewis SW et al. (1994) Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach. Psychol Med 24:995–1011

    CAS  PubMed  Google Scholar 

  49. Jones PB, Murray RM, Rodgers B (1995) Childhood risk factors for adult schizophrenia in a general population birth cohort at age 43 years. In: Mednick SA, Hollister JM (eds) Neural development in schizophrenia. Plenum Press, New York, pp 151–176

  50. Jung E, Krumm B, Biehl H et al. (1989) Mannheimer Skala zur Einschätzung von sozialer Behinderung (DAS-M). Beltz, Weinheim

  51. Kendler KS, Karkowski-Shuman L, Walsh D (1996) The risk for psychiatric illness in siblings of schizophrenics: the impact of psychotic and non-psychotic affective illness and alcoholism in parents. Acta Psychiatr Scand 94:49–55

    CAS  PubMed  Google Scholar 

  52. Kitamura T, Okazaki Y, Fujinawa A et al. (1995) Symptoms of psychoses. A factor-analytic study. Br J Psychiatry 166:236–240

    CAS  PubMed  Google Scholar 

  53. Könnecke R, Häfner H, Maurer K et al. (2000) Main risk factors for schizophrenia: increased familial loading and pre- and peri-natal complications antagonize the protective effect of oestrogen in women. Schizophr Res 44:81–93

    Article  PubMed  Google Scholar 

  54. Koreen AR, Siris SG, Chakos M et al. (1993) Depression in first episode schizophrenia. Am J Psychiatry 150:1643–1648

    CAS  PubMed  Google Scholar 

  55. Krabbendam L, Hanssen M, Bak M et al. (2004) Psychotic features in the general population. Risk factors for what? In: Gattaz WF, Häfner H (eds) Search for the causes of schizophrenia, vol V. Steinkopff, Darmstadt, pp 54–78

  56. Kraepelin E (1896). Psychiatrie, 5. Aufl. Barth, Leipzig

  57. Kraepelin E (1920) Die Erscheinungsformen des Irreseins. Z Gesamten Psychiatrie Neurologie 62:1–29

    Google Scholar 

  58. Liddle PF (1987) Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 17:49–57

    CAS  PubMed  Google Scholar 

  59. Liddle PF (1987) The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br J Psychiatry 151:145–151

    CAS  PubMed  Google Scholar 

  60. Liddle PF, Barnes TRE (1990) Syndromes of chronic schizophrenia. Br J Psychiatry 157:558–561

    CAS  PubMed  Google Scholar 

  61. Löffler W, Häfner H (1999) Dimensionen der schizophrenen Symptomatik. Nervenarzt 70:416–429

    Article  PubMed  Google Scholar 

  62. Maier W, Lichtermann D, Minges J et al. (1993) Continuity and discontinuity of affective disorders and schizophrenia: results of a controlled family study. Arch Gen Psychiatry 50:871–883

    CAS  PubMed  Google Scholar 

  63. Maier W, Minges J, Lichermann D et al. (1994) Personality variations in healthy relatives of schizophrenics. Schizophr Res 12:81–88

    Article  CAS  PubMed  Google Scholar 

  64. Maier W, Lichtermann D, Franke P et al. (2002) The dichotomy of schizophrenia and affective disorders in extended pedigrees. Schizophr Res 57:259–266

    Article  PubMed  Google Scholar 

  65. Maier W, Höfgen B, Zobel A et al. (2005) Genetic models of schizophrenia and bipolar disorder — overlapping inheritance or discrete genotypes? Eur Arch Psychiatry Clin Neurosci Special Issue (in press)

  66. Maier-Diewald W, Wittchen H-U, Hecht H et al. (1983) Die Münchner Ereignisliste (MEL)—Anwendungsmanual. Max Planck-Institut für Psychiatrie, Klinische Psychologie und Epidemiologie, München

  67. Malmberg A, Lewis G, David A et al. (1998) Premorbid adjustment and personality in people with schizophrenia. Br J Psychiatry 172:308–313

    CAS  PubMed  Google Scholar 

  68. Marcelis M, Van Os J, Sham P et al. (1998) Obstetric complications and familial morbid risk of psychiatric disorders. Am J Med Genet 81:29–36

    Article  CAS  PubMed  Google Scholar 

  69. Marneros A, Pillmann F (2004) Acute and transient psychoses. Cambdrige University Press, Cambridge

  70. Marneros A, Deister A, Rohde A (1991) Affektive, schizoaffektive und schizophrene Psychosen. Springer, Berlin Heidelberg New York

  71. Maurer K, Häfner H (2002) Early recognition inventory ERIraos: development, structure, results (Abstract). Acta Psychiatr Scand 106(Suppl):19

    Google Scholar 

  72. McGlashan TH, Carpenter WT Jr (1976) Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 33:231–239

    CAS  PubMed  Google Scholar 

  73. McGorry PD, Bell RC, Dudgeon PL et al. (1998) The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med 28:935–947

    Article  CAS  PubMed  Google Scholar 

  74. McIntosh A, Whalley H, Job D et al. (2004) Genetic liability, brain structure and symptoms of schizophrenia. In: Gattaz WF, Häfner H (eds) Search for the causes of schizophrenia, vol. V. Steinkopff, Darmstadt, pp 161–181

  75. Mundt C (1995) Psychotic continuum or distinct entities: perspectives from psychopathology. In: Marneros A, Andreasen NC, Tsuang MT (eds) Psychotic continuum. Springer, Berlin Heidelberg New York, pp 7–15

  76. Rabinowitz J, Reichenberg A, Weiser M et al. (2000) Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital. Cross-sectional analysis. Br J Psychiatry 177:26–32

    Article  CAS  PubMed  Google Scholar 

  77. Rennert H (1982) Zum Modell „Universalgenese der Psychosen“—Aspekte einer unkonventionellen Auffassung der psychischen Krankheiten. Fortschr Neurol Psychiatr 50:1–29

    CAS  PubMed  Google Scholar 

  78. Siris SG, Bench C (2003) Depression and schizophrenia. In: Hirsch SR, Weinberger DR (eds) Schizophrenia, 2nd edn. Blackwell, Oxford, pp 142–167

  79. Siris SG, Addington D, Azorin J-M et al. (2001) Depression in schizophrenia: recognition and management in the USA. Schizophr Res 47:185–197

    Article  CAS  PubMed  Google Scholar 

  80. Stefanis N, Hanssen M, Smirnis N et al. (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 32:347–358

    CAS  PubMed  Google Scholar 

  81. Tsuang MT, Fleming JA (1987) Long-term outcome of schizophrenia and other psychoses. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York, pp 88–97

  82. Van Os J, Gilvarry C, Bale R et al. (1999) A comparison of the utility of dimensional and categorical representations of psychosis. Psychol Med 29:595–606

    Article  PubMed  Google Scholar 

  83. Van Os J, Gilvarry C, Bale R et al. (1999) To what extent does symptomatic improvement result in better outcome in psychotic illness? UK700 Group. Psychol Med 29:1183–1195

    Article  PubMed  Google Scholar 

  84. Van Os J, Verdoux H, Maurice-Tison S et al. (1999) Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol 34:459–463

    Article  PubMed  Google Scholar 

  85. Van Os J, Janssen I, Hanssen M et al. (2002) Cognitive epidemiology: psychological and social risk mechanisms for psychosis. In: Häfner H (ed) Risk and protective factors in schizophrenia. Steinkopff, Darmstadt, pp 207–228

  86. Verdoux H, Maurice-Tison S, Gay B et al. (1998) A survey of delusional ideation in primary-care patients. Psychol Med 28:127–134

    Article  CAS  PubMed  Google Scholar 

  87. Weiser M (2002) Association between cognitive and behavioural functioning, non-psychotic psychiatric diagnoses, and drug abuse in adolescence, with later hospitalization for schizophrenia. In: Häfner H (ed) Risk and protective factors in schizophrenia. Steinkopff, Darmstadt, pp 163–175

  88. Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symptoms: An instruction manual for the PSE and CATEGO Program. Cambridge University Press, London

    Google Scholar 

  89. Wittchen HU, Müller N, Schmidtkunz B et al. (2000) Erscheinungsformen, Häufigkeit und Versorgung von Depressionen. Fortschritte Med 118 [Sonderheft 1]:4–10

  90. World Health Organization — WHO (1980) Follow-up history and sociodemographic description schedule (FU-HSD). 2nd unpublished draft, January 1980. WHO, Geneva

  91. World Health Organization (1988) Psychiatric disability assessment schedule. WHO, Geneva

  92. Yung AR, Phillips LJ, Yuen HP et al. (2003) Psychosis prediction: 12 month follow-up of a high risk (“prodromal”) group. Schizophr Res 60:21–32

    Article  PubMed  Google Scholar 

  93. Zeller G (unveröff.) Die Geschichte der Einheitspsychose vor Kraepelin (unveröffentlichte, durch die 77. Wanderversammlung südwestdeutscher Neurologen und Psychiater 1961 preisgekrönte Abhandlung zum Thema: Geschichte der Einheitspsychose)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Häfner.

Additional information

Nach dem Vortrag gleichen Titels von H. Häfner auf der Tagung „Affekt und Kognition“ der Gesellschaft zur Förderung empirisch begründeter Therapieansätze bei schizophrenen Menschen, Münsterlingen (CH), 11.–12. November 2004

Die ABC-Schizophreniestudie wurde und wird von der Deutschen Forschungsgemeinschaft (DFG) im Rahmen des Sonderforschungsbereichs 258 am Zentralinstitut für Seelische Gesundheit vom 1. Januar 1987 bis 31. Dezember 1998, vom 1. Januar 1999 bis 30. September 2002 und ab 1.1.2005 bis 31.12.2007 im Einzelverfahren gefördert.

The ABC study was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Special Research Branch (Sonderforschungsbereich) 258 at the Central Institute of Mental Health from January 1, 1987 to December 31, 1998. From January 1, 1999 to September 30, 2002 it was funded by the DFG as an independent project, and that funding will continue from January 1, 2005 to December 31, 2007.

This paper was written within the framework of the German Research Network on Schizophrenia and was funded by the German Federal Ministry for Education and Research BMBF (grant 01GI 0236).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maurer, K., Trendler, G., Schmidt, M. et al. Schizophrenie und Depression. Nervenarzt 77, 809–822 (2006). https://doi.org/10.1007/s00115-005-1920-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-005-1920-y

Schlüsselwörter

Keywords

Navigation